NPS Pharmaceuticals, Inc. (NPSP) Recognized by National Organization for Rare Disorders for Gattex© as an Innovative Treatment for Patients With Short Bowel Syndrome
5/15/2013 9:59:17 AM
More...
|
Media Alert: BioNJ, National Organization for Rare Disorders and 16 New Jersey Patient Advocacy Groups Joining Forces on March 4 to Highlight Rare Disease Day
3/4/2013 10:26:16 AM
More...
|
National Organization for Rare Disorders, BioNJ and Patient Advocacy Groups to Collaborate on Rare Disease Day Event at New Jersey State House
2/13/2013 11:39:26 AM
More...
|
National Organization for Rare Disorders Applauds SSA for Expanding Compassionate Allowances List
4/13/2012 8:26:01 AM
More...
|
National Organization for Rare Disorders Supports FAST Act Introduced by Representatives Stearns and Towns
3/9/2012 9:26:43 AM
More...
|
Landmark National Organization for Rare Disorders Study Concludes FDA is Flexible in Reviewing Therapies for Rare Diseases
10/11/2011 5:56:48 AM
More...
|
Drug Information Association and National Organization for Rare Disorders Hold 1st US Conference on Rare Diseases and Orphan
10/7/2011 2:02:11 PM
More...
|
National Organization for Rare Disorders and Drug Information Association to Host Conference on Rare Diseases and Orphan Products
9/15/2011 11:18:58 AM
More...
|
National Organization for Rare Disorders Submits Citizen's Petition to FDA Regarding Orphan Drug Reviews
9/7/2011 12:06:11 PM
More...
|
Alexion Pharmaceuticals Inc. (ALXN) Joins National Organization for Rare Disorders, EURORDIS and Other Patient Advocacy Groups in Supporting the Goals of Rare Disease Day 2011
2/28/2011 9:13:53 AM
More...
|
|